Department of Psychiatry
The Yale Department of Psychiatry is dedicated to providing the highest quality education in the field of Psychiatry; to providing leaders and leadership for the field; and to acquiring and disseminating new scientific knowledge pertinent to the causes and treatments of severe neuropsychiatric disorders and to serving as a model of exemplary mental healthcare for students and society.
Contents
Copy Link
- EducationYale offers undergraduate and graduate medical education programs as well as training opportunities in psychology and research. Our residents, fellows, and faculty are committed to excellence and innovation in student education.
- Residency: Why Train at Yale?The training experiences, mentorship, and individualized education plan provided by Yale's residency program will build a solid foundation for the rest of your career.
- ResearchCollaboration is central to our success, with interdisciplinary and translational teams of basic and clinical scientists working together to rapidly bring breakthroughs from the lab to the clinic.
- Centers, Clinics & ProgramsOur research specialty clinics are organized around specific psychiatric conditions, allowing dedicated teams of clinicians and scientists to work together to meet patients’ unique needs and to translate the latest science into new breakthroughs.
- Patient CareThe range of clinical services spans all ages, from adolescent through geriatric populations, and all illnesses from the most severe and debilitating of psychoses and major affective disorders, to personality and addictive disorders.
- Psychology SectionWith more than 200 full-time and voluntary faculty, the Psychology Section leads clinical care, education, and research, collaborating across disciplines locally, nationally, and internationally.
- Faculty DirectoryLeaders in the field of psychiatry, our faculty conduct cutting-edge research, implement the latest advances in clinical care, and develop innovative and nationally recognized curricula.
Chair's Welcome
Welcome to the website of the Department of Psychiatry at Yale School of Medicine. Yale is a remarkably exciting academic psychiatry community distinguished by the impact, breadth, and depth of its clinical, training, and research programs.
About the Department & Our Mission
Psychology Section
With over 200 full time and voluntary faculty, the Psychology Section within the Yale Department of Psychiatry is one of the largest and most accomplished groups of psychologists in an academic medical center.
Latest News
Copy Link
- November 13, 2026Source: Psychiatric Times
A Veterans Day Salute: Lessons From 1918 and 2026 for Psychiatrists
- November 12, 2026Source: WTNH-TV News 8 (with Arman Fesharaki-Zadeh, MD, PhD)
What Doctors Wish More People Understood About Alzheimer’s Disease
- November 12, 2026
Yusim Participates in United Nations Panel in New York
- November 11, 2026
Jordan Co-Presents Colloquium at Yale Divinity School
- November 10, 2026Source: Psyche
How to Help Someone Whose Thinking Seems Delusional
- November 10, 2026
Kong Keynote Speaker at Connecticut Psychological Association Convention
- November 09, 2026
Q&A with Ilan Harpaz-Rotem, PhD: The Unbroken Integrative Psycho-Trauma Care Model
- November 09, 2026Source: American Psychological Association (with Amber Childs, PhD)
AI Essentials for Practitioners
The collaboration between Yale School of Medicine and Yale New Haven Psychiatric Hospital (YNHPH) has resulted in the translation of world-leading research to patient-centered care. Pioneers in the laboratories and in the clinics are transforming lives through the Interventional Psychiatric Services (IPS). IPS is the culmination of research and clinical practice to provide patients who have not been successful with more traditional treatments an opportunity for a better life. IPS includes comprehensive, specialty consultations, electroconvulsive therapy (ECT), Ketamine Infusion Therapy (KIT) and Transcranial Magnetic Stimulation (TMS). Click on the Yale Psychiatry logo above to view a video about the service.
Parkinson disease not only affects a person's mobility, but also many other symptoms in a person with Parkinson disease life. Depression is a very common symptom caused by Parkinson disease, and adequate treatment is imperative for patients to feel their best. Through collaborations between Drs. Sophie E. Holmes and Gerard Sanacora of Psychiatry and the Movement Disorders group, researchers are conducting the first clinical trial of ketamine as an antidepressant in PD. Due to how it works in the brain – its ability to help form new synapses – they have strong reason to believe it will effectively treat depression, and possibly other symptoms, in PD. Using brain imaging before and after treatment will help to determine how it works in the brains of people with Parkinson’s for the first time. The trial is taking place at the Yale New Haven Psychiatric Hospital. In this video, hear more about the trial from Drs. Holmes and Sanacora and from Brenda, who talks about her experience participating in this groundbreaking research.
Department of Psychiatry Upcoming Events
Copy Link
Everyone Minhee SungThis session will be held in a virtual format.Everyone James Swain, MD, PhDEveryone Deepak Cyril Dsouza, MBBS, MD - Romina Mizrahi, PhD - Andrea Hohmann, PhDVirtual- This webinar will be held via Zoom. Please click below to register. https://yale.zoom.us/meeting/register/msLFvkP4S5uUZtjQx81DsQ
Everyone Julie Kaplow, PhD, ABPP
Yale Only Marc Potenza, PhD, MD
What Do You Need?
- Psychiatry Grand RoundsPsychiatry Grand Rounds are always compelling and topical.
- Patient Care: Quick LinksServices affiliated with Yale such as CMHC, the VA, YNHH, and Yale Behavioral Health.
- Faculty: Wellbeing & Mental HealthIt is critical to maintain focus on health and wellness.
- Recognize ExcellenceShare good news about faculty, students, staff, and trainees.